Molluscum Contagiosum
&nbsp;
Molluscum Contagiosum, also called water warts, is a common superficial skin infection caused by the poxvirus. It predominantly affects school-aged children, sexually active young adults, and immunocompromised individuals.
The virus is transmitted mainly by direct contact with infected skin, which can be sexual, nonsexual, or autoinoculation. It is common in children and generally presents with asymptomatic lesions; however, it can present with pruritus, erythema, and on some occasions, bacterial superinfections with inflammation and pain.
&nbsp;
Molluscum Contagiosum Epidemiology Segmentation in the 7MM
&nbsp;
<ul>
<li class="ql-align-justify">Total Prevalent Population of Molluscum Contagiosum</li>
<li class="ql-align-justify">Gender-specific Cases of Molluscum Contagiosum</li>
</ul>
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/molluscum-contagiosum-mc-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Molluscum Contagiosum Epidemiological Insights Observed in the 7MM (2021)</a>
&nbsp;
<ul>
<li class="ql-align-justify">The total incident cases of Molluscum Contagiosum observed in the 7MM was observed to be 12 Million in the year 2021</li>
<li class="ql-align-justify">The highest diagnosed Molluscum Contagiosum population accounting for 6 million cases, was found in the United States, followed by 5 million (EU5), and 1 million (Japan) in the year 2021</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/molluscum-contagiosum-mc-market" target="_blank" rel="noopener noreferrer">Molluscum Contagiosum Market Insight</a>
&nbsp;
The market size of Molluscum Contagiosum in the 7MM was found to be approximately USD 2 billion in 2021. &nbsp;
&nbsp;
Molluscum Contagiosum Market Strengths
&nbsp;
The expected launch of newly approved therapies, VP-102 and SB206, is likely to spur market growth in the near future. These might lead to a revolutionary class of topical therapies (drug-device combo) that can offer a safe and effective alternative to specific treatments offered to MC patients.&nbsp;
&nbsp;
Molluscum Contagiosum Market Opportunities
&nbsp;
Introduction of consistent and precise application method containing a controlled formulation with a proven dosing schedule, with testing completed in large populations of patients with molluscum.
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/molluscum-contagiosum-pipeline-insight" target="_blank" rel="noopener noreferrer">Molluscum Contagiosum Emerging Drugs</a>
&nbsp;
The emerging drugs in the Molluscum Contagiosum market are
<ul>
<li class="ql-align-justify">VP-102/ Cantharidin</li>
<li class="ql-align-justify">SB206, and others</li>
</ul>
&nbsp;
Molluscum Contagiosum Key Players&nbsp;
&nbsp;
The key players working in the Molluscum Contagiosum market are
&nbsp;
<ul>
<li class="ql-align-justify">Verrica Pharmaceuticals</li>
<li>&nbsp;</li>
<li class="ql-align-justify">Novan and Ligand Pharmaceuticals, and others</li>
</ul>
&nbsp;

Molluscum Contagiosum Market

Molluscum Contagiosum Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape